Heterogeneity and individuality: microRNAs in mental disorders
- PMID: 25395183
- DOI: 10.1007/s00702-014-1338-4
Heterogeneity and individuality: microRNAs in mental disorders
Abstract
MicroRNAs are about 22 nucleotide long single-stranded RNA molecules, negatively regulating gene expression of a single gene or a gene network. In neural tissues, they have been implicated in developmental and neuroplasticity-related processes, such as neurogenesis, differentiation, apoptosis and long-term potentiation. Their molecular mode of action is reminiscent of findings of genome-wide association studies in mental disorders, unable to attribute the risk of disease to a specific gene, but rather to multiple genes, gene-networks and gene-environment interaction. As such, microRNAs are an attractive target for research. Here, we review clinical studies conducted in humans on microRNAs in mental disorders with a particular focus on schizophrenia, bipolar disorder, major depressive disorder and anxiety disorders. The majority of clinical studies have focused on schizophrenia. The most robust finding has been reported for rs1625579 located in MIR137HG, which was associated with schizophrenia on a genome-wide level. Concerning bipolar disorder, major depression and anxiety disorders, promising results have been published, but only a considerably smaller number of clinical studies is available and genome-wide association studies did not suggest a direct link to microRNAs so far. Expression of microRNAs as biomarkers of mental disorders and treatment response is currently emerging with preliminary results. Larger-scaled genetic and functional studies along with translational research are needed to enhance our understanding of microRNAs in mental disorders. These studies will aid in disentangling the complex genetic nature of these disorders and possibly contribute to the development of novel, individualized diagnostic and therapeutic approaches.
Similar articles
-
New technologies provide insights into genetic basis of psychiatric disorders and explain their co-morbidity.Psychiatr Danub. 2010 Jun;22(2):190-2. Psychiatr Danub. 2010. PMID: 20562745 Review.
-
MicroRNA and Posttranscriptional Dysregulation in Psychiatry.Biol Psychiatry. 2015 Aug 15;78(4):231-9. doi: 10.1016/j.biopsych.2014.12.009. Epub 2014 Dec 18. Biol Psychiatry. 2015. PMID: 25636176 Review.
-
Diagnostic and therapeutic potential of microRNAs in neuropsychiatric disorders: Past, present, and future.Prog Neuropsychopharmacol Biol Psychiatry. 2017 Feb 6;73:87-103. doi: 10.1016/j.pnpbp.2016.03.010. Epub 2016 Apr 9. Prog Neuropsychopharmacol Biol Psychiatry. 2017. PMID: 27072377 Free PMC article. Review.
-
When less is more--microRNAs and psychiatric disorders.Acta Psychiatr Scand. 2014 Apr;129(4):241-56. doi: 10.1111/acps.12191. Epub 2013 Aug 17. Acta Psychiatr Scand. 2014. PMID: 23952691 Review.
-
Specific and common genes implicated across major mental disorders: a review of meta-analysis studies.J Psychiatr Res. 2015 Jan;60:1-13. doi: 10.1016/j.jpsychires.2014.09.014. Epub 2014 Sep 28. J Psychiatr Res. 2015. PMID: 25287955 Review.
Cited by
-
Polymorphisms in MicroRNA Genes Associated with Schizophrenia Susceptibility but Not with Effectiveness of MECT.Comput Math Methods Med. 2021 Dec 13;2021:1959172. doi: 10.1155/2021/1959172. eCollection 2021. Comput Math Methods Med. 2021. Retraction in: Comput Math Methods Med. 2023 Dec 6;2023:9765021. doi: 10.1155/2023/9765021. PMID: 34938351 Free PMC article. Retracted.
-
Association between single nucleotide polymorphisms in MiR219-1 and MiR137 and susceptibility to schizophrenia in a Chinese population.FEBS Open Bio. 2015 Aug 28;5:774-8. doi: 10.1016/j.fob.2015.08.008. eCollection 2015. FEBS Open Bio. 2015. PMID: 26609515 Free PMC article.
-
The Computational Analysis Conducted on miRNA Target Sites in Association with SNPs at 3'UTR of ADHD-implicated Genes.Cent Nerv Syst Agents Med Chem. 2020;20(1):58-75. doi: 10.2174/1871524919666191014104843. Cent Nerv Syst Agents Med Chem. 2020. PMID: 31660846 Free PMC article.
-
Epigenetics of Fear, Anxiety and Stress - Focus on Histone Modifications.Curr Neuropharmacol. 2024;22(5):843-865. doi: 10.2174/1570159X21666230322154158. Curr Neuropharmacol. 2024. PMID: 36946487 Free PMC article.
-
Pathogenetic and therapeutic applications of microRNAs in major depressive disorder.Prog Neuropsychopharmacol Biol Psychiatry. 2016 Jan 4;64:341-8. doi: 10.1016/j.pnpbp.2015.02.003. Epub 2015 Feb 14. Prog Neuropsychopharmacol Biol Psychiatry. 2016. PMID: 25689819 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials